Senior insider sale
Chief Executive Officer at AURINIA PHARMACEUTICALS INC. — senior position signals high conviction
$49.68M
3.14M shares
What this filing means
GREENLEAF PETER plans to sell 3.14M shares of AURINIA PHARMACEUTICALS INC. valued at approximately $49.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001950047-26-004312
DirectorOfficer· Chief Executive Officer
Since Jan 2021
3.14M
Shares to sell
$49.68M
Approx. market value
3.14M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
5/11/2026
3.14MTotal acquired3.14M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/11/2026 | Exercise of options under a registered plan Cash | 3.14M | — |
| Total | 3.14M | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.14M
Market value
$49.68M
5/11/2026
Total
Units
3.14M
Value
$49.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/11/2026 | 3.14M | $49.68M | NASDAQ | Planned |
| Total | 3.14M | $49.68M | ||